South Korea

REMED (302550)

Track

Track

REMED experienced a single notable divestment recently, as Lee Geun Yong executed a planned sale of 1,692,620 shares valued at approximately 5 billion KRW on November 13, 2026. This transaction occurred amidst a 18.6% decline in the stock price over the past ninety days, reflecting significant liquidity activity by an insider.
Ticker: 302550 Exchange: KOREA
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
LEE GEUN YONG (이근용) Unclassified position (대표집행임원) Officer Large shareholder
Transaction date
Planned sale
Price
474.15
Quantity 4,020
Value ₩1,936,877
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-14 2026-11-13 PlS Planned sale LEE GEUN YONG (이근용)

Unclassified position (대표집행임원)

Officer Large shareholder
4,020
474.15
₩1,936,877 		4,020 474.15 ₩1,936,877
Explore more

More insider trading research around REMED

More insider trades in South Korea
Insider trading in Asia-Pacific